David Flannery, MD, Director of Telegenetics and Digital Genetics at Cleveland Clinic, joins the podcast to discuss leveraging technology to make up for the lack of MD Geneticists in the country, useful tools that he is using in his field, how he's thinking about growth and adding value to his organization, and more. Want to network with peers and hear more conversations like this? Apply to be one of our complimentary guest reviewers at our upcoming HIT + Digital Health + RCM Meeting Oct, 3-6 2023 here.
Summary
Leveraging Technology in Genetics with Dr. David Flannery
Introduction
Dr. David Flannery is the director of Telegen Genetics and Digital Genetics at Cleveland Clinic, and he joins the podcast to discuss how technology is being used to make up for the lack of MD Geneticists in the country. He talks about the useful tools he is using in his field, how he's thinking about growth and adding value to his organization, and more. If you want to network with peers and hear more conversations like this, apply to be one of our complimentary guest reviewers at our upcoming HIT + Digital Health + RCM Meeting on Oct, 3-6 2023.
Leveraging Digital Tools to Increase Access
Dr. Flannery works with patients to provide genetic care before birth all the way up to old age. Digital tools such as telemedicine, eConsults, and chatbots have been implemented to increase access and facilitate more efficient use of practitioners. These tools help to practice higher on one's license, which ultimately benefits both patients and practitioners. Additionally, Cleveland Clinic is working on a Project ECHO program, which is a tele-mentoring program for primary care providers to get advice from experts.
Incorporating Precision Medicine into the EHR System
Dr. Flannery is a pioneer in the use of telemedicine for genetics. He is currently working to incorporate pharmacogenomics into Cleveland Clinic's EHR system. To achieve this, he has learned a lot from other organizations like the University of Minnesota, who have already established Project ECHO for pharmacogenomics. In order to make precision medicine work, it is essential to get genetic test results into the EHR system in an actionable way. Therefore, Cleveland Clinic is looking to learn from Geisinger Health System and North Shore Health, who have already started projects to do this.
Conclusion
Technology plays an essential role in increasing access and improving patient care in the field of genetics. Dr. David Flannery is at the forefront of incorporating digital tools and pharmacogenomics into Cleveland Clinic's practice. Applying these tools ultimately benefits patients and practitioners, and Cleveland Clinic is looking to learn from other organizations to continue this growth. If you're interested in networking with peers and learning more about these topics, apply to be one of our complimentary guest reviewers at our upcoming HIT + Digital Health + RCM Meeting on Oct, 3-6 2023.
Note: This is an AI generated transcript, not edited by a staff writer and is solely intended for educational purposes. If you have any questions/concerns, reach out to podcasts@beckershealthcare.com
This episode aired on 05/15/2023 and can be listened here.
Subscribe to Beckers Healthcare Podcast here.